Protalix Biotherapeutics, Inc. (PLX)
1.985
0.00 (0.00%)
USD |
NYAM |
Jun 10, 16:00
1.98
0.00 (0.00%)
After-Hours: 18:51
Protalix Biotherapeutics EPS Diluted (TTM) : 0.1833 for March 31, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | 0.1833 |
| December 31, 2025 | -0.0845 |
| September 30, 2025 | 0.0695 |
| June 30, 2025 | 0.074 |
| March 31, 2025 | 0.042 |
| December 31, 2024 | 0.0263 |
| September 30, 2024 | -0.1421 |
| June 30, 2024 | -0.2189 |
| March 31, 2024 | 0.0225 |
| December 31, 2023 | 0.0309 |
| September 30, 2023 | 0.0409 |
| June 30, 2023 | 0.012 |
| March 31, 2023 | -0.3121 |
| December 31, 2022 | -0.3075 |
| September 30, 2022 | -0.3811 |
| June 30, 2022 | -0.4012 |
| March 31, 2022 | -0.5359 |
| December 31, 2021 | -0.6231 |
| September 30, 2021 | -0.4653 |
| June 30, 2021 | -0.5081 |
| March 31, 2021 | -0.3886 |
| December 31, 2020 | -0.1556 |
| September 30, 2020 | -0.1474 |
| June 30, 2020 | -0.2523 |
| March 31, 2020 | -0.6462 |
| Date | Value |
|---|---|
| December 31, 2019 | -1.232 |
| September 30, 2019 | -1.617 |
| June 30, 2019 | -1.737 |
| March 31, 2019 | -1.792 |
| December 31, 2018 | -1.949 |
| September 30, 2018 | -2.683 |
| June 30, 2018 | -3.224 |
| March 31, 2018 | -3.247 |
| December 31, 2017 | -7.40 |
| September 30, 2017 | -6.511 |
| June 30, 2017 | -6.311 |
| March 31, 2017 | -6.811 |
| December 31, 2016 | -2.911 |
| September 30, 2016 | -3.10 |
| June 30, 2016 | -2.90 |
| March 31, 2016 | -2.40 |
| September 30, 2015 | -2.40 |
| June 30, 2015 | -2.90 |
| March 31, 2015 | -3.10 |
| December 31, 2014 | -3.30 |
| September 30, 2014 | -3.60 |
| June 30, 2014 | -3.30 |
| March 31, 2014 | -3.30 |
| December 31, 2013 | -3.00 |
| September 30, 2013 | -2.90 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Agenus, Inc. | 1.670 |
| Altimmune, Inc. | -0.9376 |
| Humacyte, Inc. | -0.5747 |
| Amgen, Inc. | 14.38 |
| BioCryst Pharmaceuticals, Inc. | -1.776 |